Welcome to lbbc.org's website community for people living with metastatic breast cancer. We are dedicated to assisting you, and these pages offer easy access to a wealth of cutting-edge information specific to your needs.
In this community, you can read about the latest news on advanced disease, treatments and updates on clinical trials. Use the navigation bar on the left to quickly and easily access the topics of interest to you.
We hope the information and support offered in this section brings you comfort and enables you to make informed decisions regarding your physical and emotional health.
Sheila Glover writes about her experience living with metastatic breast cancer.
Every dollar you give helps LBBC continue to provide information and support at little to no cost.
Researchers seek 600 men or postmenopausal women who have hormone receptor-positive, HER2-negative breast cancer that has spread to tissue, lymph nodes or another area of the body for a phase III study.
The phase II HERMIONE study is designed to compare MM-302, a new anti-HER2 medicine, plus trastuzumab, to chemotherapy of a physician’s choice, plus trastuzumab.
Most, if not all, cancer treatments have some kind of side effect. And, living with metastatic breast cancer means being in treatment long-term. Managing the side effects of the treatments you need is an important part of living well with metastatic disease.
This March, Living Beyond Breast Cancer expert Evelyn Robles-Rodriguez, RN, MSN, NPC, AOCN answers your questions about what side effects you may experience, how to handle them, what to do if a side effect becomes too much and what your healthcare team can do to help.